BeOne Medicines AG (HKG:6160)
Hong Kong · Delayed Price · Currency is HKD 207.00
-1.60 (-0.77%)
Sep 10, 2026, 4:08 PM HKT
BeOne Medicines AG Market Cap
BeOne Medicines AG has a market cap or net worth of 312.97 billion as of September 10, 2026. Its market cap has increased by 4.02% in one year.
Market Cap
312.97B
Enterprise Value
289.06B
Revenue
48.06B
Ranking
n/a
PE Ratio
60.86
Stock Price
207.00
ChartMarket Cap Chart
Since February 3, 2016, BeOne Medicines AG's market cap has increased from 6.70B to 312.97B, an increase of 4,573.36%. That is a compound annual growth rate of 43.68%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 10, 2026 | 312.97B | 19.60% |
| Dec 31, 2025 | 261.67B | 71.29% |
| Dec 31, 2024 | 152.77B | 4.09% |
| Dec 29, 2023 | 146.76B | -17.60% |
| Dec 30, 2022 | 178.11B | -17.96% |
| Dec 31, 2021 | 217.12B | 19.19% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| WuXi Biologics | 200.43B |
| Innovent Biologics | 174.44B |
| Sichuan Kelun-Biotech Biopharmaceutical | 114.97B |
| Sino Biopharmaceutical | 99.91B |
| Akeso | 88.61B |
| Genscript Biotech | 73.65B |
| RemeGen | 66.99B |
| Biocytogen Pharmaceuticals (Beijing) | 56.24B |